
Medicine
FDA approves much-debated Alzheimer’s drug panned by experts
The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer's disease.
4 years ago
Experts see strides on AIDS, but COVID-19 halted progress
Saturday marks the 40th anniversary of the first report that brought AIDS to the attention of the public.
4 years ago
Lack of diversity in clinical trials has hurt patients of color. A new program aims to change that
A lack of diversity has persisted for years in the U.S, limiting patients' access to potentially effective new drugs and therapies.
4 years ago
How do COVID-19 vaccines affect people who are immunocompromised?
If you have certain conditions, or are taking certain medications, parts of your immune system may function less effectively. Here’s what we know.
4 years ago
Hospitals, insurers invest big dollars to tackle patients’ social needs
Eager to control costs, health systems and insurers try to address food insecurity, housing, and more. Yet the evidence is mixed that these efforts work.
4 years ago
Listen 5:15Menopause typically happens during a time of life when women need to be on top of their game; managing their careers, raising children, a ...
Air Date: May 25, 2021
Listen 36:29Fully vaccinated and maskless: What does that mean for safety?
Some people feel stressed: How can you know who is fully vaccinated? WHYY’s Health Desk Help Desk offers a guide to the CDC’s mask guidance.
4 years ago
Listen 2:27Will I need to get a COVID-19 booster shot?
While pharmaceutical companies making COVID-19 vaccines say it’s likely you’ll need a booster, scientists say it’s too soon to tell. Here’s what we do know so far.
4 years ago
Listen 2:12I’ve already had COVID-19. Do I need one vaccine shot or two?
How do the vaccines boost immunity? Do people who’ve had the virus even need a dose? WHYY’s Health Desk Help Desk asked about the research.
4 years ago
Listen 1:55Herd immunity, mask confusion and a nudge for the vaccine hesitant
This hour, worry that we won't reach herd immunity as vaccine demand slows, the confusion about new CDC guidelines for the vaccinated, and using a nudge for vaccine hesitant.
Air Date: May 5, 2021 10:00 am
Listen 49:45The rarest of COVID vaccine reactions: One woman’s story of Guillain-Barre
You’re more likely to win the lottery than develop this severe COVID vaccine reaction. But for a Manayunk woman, the lowest of odds changed her life.
4 years ago
Listen 1:15New study looks at medication assisted drug treatment after Medicaid expansion
Even as more people get treatment overall, people with criminal justice involvement still remain less likely to get medication for opioid use disorder.
4 years ago
US health panel urges restarting J&J COVID-19 vaccinations
A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.
4 years ago
Half of U.S. adults have received at least one COVID-19 shot
The U.S. cleared the 50% mark just a day after the reported global death toll from the coronavirus topped a staggering 3 million.
4 years ago
N.J.’s new legal weed market faces municipal bans, slow adoption by medical industry
The N.J. Cannabis Regulatory Commission held its first meeting and began writing the rules and regulations necessary before legal weed sales can start.
4 years ago